FT Biotechnology Intenational Yearbook
The Financial Times has announced a new addition to its InternationalYearbook Series - The Financial Times Biotechnology International Yearbook 1997.
The directory, which is produced in association with pharmaceutical development company Connect Pharma, lists alphabetically the top companies in the sector, and gives company analysis and financial details on around 300 leading companies in the industry. Although biotechnology as a subject is wide-ranging and relevant to a variety of industries, the Yearbook concentrates on human health care, animal health care and agriculture.
The Yearbook is available, priced L185.00, from Cartermill International Ltd, Maple House, 149 Tottenham Court Road, London W1P 9LL, UK. Phone: +44 171 896 2424; fax: +44 171 896 2449.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze